Portola Pharmaceuticals, Inc. Restructuring Charges
Portola Pharmaceuticals, Inc. reported Restructuring Charges of $1.90 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2020-05-11
- Portola Pharmaceuticals, Inc. restructuring charges for the quarter ending 2020-03-31 was $1.90M.
- Portola Pharmaceuticals, Inc. restructuring charges for the quarter ending 2013-12-31 was $0.00.
- Portola Pharmaceuticals, Inc. restructuring charges for the quarter ending 2013-09-30 was $0.00.
- Portola Pharmaceuticals, Inc. restructuring charges for fiscal 2013 was $79.00K.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 8 month | Restructuring Charges 9 month | Restructuring Charges 11 month | Restructuring Charges 12 month | Restructuring Charges 14 month |
|---|---|---|---|---|---|---|---|
| 2020-03-31 | $1.90M 10-Q · filed 2020-05-11 | ||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $0.00 derived: sum of 2 quarters · filed 2015-03-02 | $79.00K 10-K · filed 2015-03-02 | $698.00K 10-K · filed 2015-03-02 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $79.00K 10-Q · filed 2013-11-06 | $698.00K 10-Q · filed 2013-11-06 | ||||
| 2013-06-30 | $79.00K 10-Q · filed 2013-08-14 | $698.00K 10-Q · filed 2013-08-14 |